A comparison of estimators to evaluate the discriminatory power of time-to-event models

Statistics in Medicine

Volumn 31, Issue 23, 2012, Pages 2588-2609

  Schmid, Matthias ^a   Potapov, Sergej ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Concordance probability; Cox regression; Discrimination measures; Molecular markers; Risk prediction; Survival analysis

Indexed keywords

ACCURACY; ANALYSIS OF VARIANCE; ANALYTICAL ERROR; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISCRIMINANT ANALYSIS; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROPORTIONAL HAZARDS MODEL; SAMPLE SIZE;

AREA UNDER CURVE; BREAST NEOPLASMS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DNA, NEOPLASM; FEMALE; HUMANS; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84866436885     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5464     Document Type: Article

References (44)

1. Pepe MS, Zheng Y, Jin Y, Huang Y, Parikh CR, Levy WC.Evaluating the ROC performance of markers for future events. Lifetime Data Analysis 2008; 14(1):86-113.
2. Steyerberg EW, Vickers AJ, Cook NR, Gerds TA, Gönen M, Obuchowski N, Pencina MJ, Kattan MW.Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21(1):128-138.
3. Hielscher T, Zucknick M, Werft W, Benner A.On the prognostic value of survival models with application to gene expression signatures. Statistics in Medicine 2010; 29(7-8):818-829.
4. van't Veer LJ, Dai H, vande Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, vander Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH.Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415(6871):530-536.
5. Cai T, Pepe MS, Zheng Y, Lumley T, Jenny NS.The sensitivity and specificity of markers for event times. Biostatistics 2006; 7(2):182-197.
6. Uno H, Cai T, Tian L, Wei LJ.Evaluating prediction rules for t-year survivors with censored regression models. Journal of the American Statistical Association 2007; 102(478):527-537.
7. Cox DR.Regression models and life tables (with discussion). Journal of the Royal Statistical Society, Series B 1972; 34(2):187-220.
8. Gönen M, Heller G.Concordance probability and discriminatory power in proportional hazards regression. Biometrika 2005; 92(4):965-970.
9. Subramanian J, Simon R.An evaluation of resampling methods for assessment of survival risk prediction in high-dimensional settings. Statistics in Medicine 2011; 30(6):642-653.
10. Antolini L, Boracchi P, Biganzoli E.A time-dependent discrimination index for survival data. Statistics in Medicine 2005; 24(24):3927-3944.
11. Schemper M, Stare J.Explained variation in survival analysis. Statistics in Medicine 1996; 15(19):1999-2012.
12. Rosthoj S, Keiding N.Explained variation and predictive accuracy in general parametric statistical models: the role of model misspecification. Lifetime Data Analysis 2004; 10(4):461-472.
13. Song X, Zhou X-H.A semiparametric approach for the covariate specific ROC curve with survival outcome. Statistica Sinica 2008; 18(3):947-965.
14. Heagerty PJ, Zheng Y.Survival model predictive accuracy and ROC curves. Biometrics 2005; 61(1):92-105.
15. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA.Evaluating the yield of medical tests. Journal of the American Medical Association 1982; 247(18):2543-2546.
16. Harrell FE, Lee KL, Califf RM, Pryor DB, Rosati RA.Regression modeling strategies for improved prognostic prediction. Statistics in Medicine 1984; 3(2):143-152.
17. Chambless LE, Diao G.Estimation of time-dependent area under the ROC curve for long-term risk prediction. Statistics in Medicine 2006; 25(20):3474-3486.
18. Uno H, Cai T, Pencina MJ, D'Agostino RB, Wei LJ.On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Statistics in Medicine 2011; 30:1105-1117.
19. Simon R.Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling. Journal of the National Cancer Institute 2006; 98(17):1169-1171.
20. vande Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, vander Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R.A gene-expression signature as a predictor of survival in breast cancer. New England Journal of Medicine 2002; 347(25):1999-2009.
21. Potapov S, Adler W, Schmid M.survAUC: estimators of prediction accuracy for time-to-event data, 2011. R package version 1.0-4. http://cran.r-project.org/web/packages/survAUC/index.html.
22. Klein JP, Moeschberger ML.Survival Analysis - Techniques for Censored and Truncated Data, (2 edn). Springer: New York, 2003.
23. Begg CB, Cramer LD, Venkatraman ES, Rosai J.Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model. Statistics in Medicine 2000; 19(15):1997-2014.
24. vander Laan MJ, Robins JM.Unified Methods for Censored Longitudinal Data and Causality. Springer: New York, 2003.
25. Hung H, Chiang C-T.Estimation methods for time-dependent AUC models with survival data. Canadian Journal of Statistics 2010; 38(1):8-26.
26. R Development Core Team.R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2011. http://www.R-project.org.
27. Heagerty PJ.risksetroc: Riskset ROC curve estimation from censored survival data, 2011. R package version 1.0-3. http://cran.r-project.org/web/packages/risksetROC/index.html.
28. Eden P, Ritz C, Rose C, Fernö M, Peterson C.'Good old' clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. European Journal of Cancer 2004; 40(12):1837-1841.
29. Boulesteix AL, Sauerbrei W.Added predictive value of high-throughput molecular data to clinical data and its validation. Briefings in Bioinformatics 2011; 12:215-229.
30. van Houwelingen HC, Bruinsma T, Hart AAM, van't Veer LJ, Wessels LFA.Cross-validated Cox regression on microarray gene expression data. Statistics in Medicine 2006; 25(18):3201-3216.
31. Goeman J.penalized: L1 (Lasso) and L2 (Ridge) penalized estimation in GLMs and in the Cox model, 2011. R package version 0.9-34. http://cran.r-project.org/web/packages/penalized/index.html.
32. Grambsch P, Therneau T.Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81(3):515-26.
33. Kent JT, O'Quigley J.Measures of dependence for censored survival data. Biometrika 1988; 75(3):525-534.
34. Nagelkerke NJD.A note on a general definition of the coefficient of determination. Biometrika 1991; 78(3):691-692.
35. Xu R, O'Quigley J.A measure of dependence for proportional hazards models. Journal of Nonparametric Statistics 1999; 12(1):83-107.
36. O'Quigley J, Xu R, Stare J.Explained randomness in proportional hazards models. Statistics in Medicine 2005; 24(3):479-489.
37. Graf E, Schmoor C, Sauerbrei W, Schumacher M.Assessment and comparison of prognostic classification schemes for survival data. Statistics in Medicine 1999; 18(17-18):2529-2545.
38. Schemper M, Henderson R.Predictive accuracy and explained variation in Cox regression. Biometrics 2000; 56(1):249-255.
39. Gerds TA, Schumacher M.Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biometrical Journal 2006; 48(6):1029-1040.
40. Schmid M, Hielscher T, Augustin T, Gefeller O.A robust alternative to the Schemper-Henderson estimator of prediction error. Biometrics 2011; 67(2):524-35.
41. Pencina MJ, D'Agostino RB.Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statistics in Medicine 2004; 23(13):2109-2123.
42. Korn EL, Simon R.Measures of explained variation for survival data. Statistics in Medicine 1990; 9(5):487-503.
43. Pencina MJ, D'Agostino Sr RB, D'Agostino Jr RB, Vasan RS.Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine 2008; 27(2):157-172.
44. Vickers AJ, Elkin EB.Decision curve analysis: a novel method for evaluating prediction models. Medical Decision Making 2006; 26(6):565-574.